Find your path to Justin
Sign up to see every warm intro you have to Justin
- Paths you didn't know you had: your email and LinkedIn already hold routes to Justin. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Justin Kao is a partner at DFJ Growth who invests in companies transforming human health. He co-founded Helix in 2015, serving as founding CEO and later chief business officer, where he led partnerships with health systems, payers, and life sciences companies and worked on the company's COVID-19 diagnostic testing efforts. Before DFJ Growth, he was a partner at Khosla Ventures and an investor at Warburg Pincus, and earlier worked at Boston Consulting Group and Onyx Pharmaceuticals. He holds a BS in chemical engineering and MS in bioengineering from Stanford, plus a JD from Stanford Law School and an MBA from Stanford Graduate School of Business.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechDeep TechDigital HealthHealthtech
Deals · 2
Inflammatix, Inc.Board seat
via DFJ · filed Mar 2021 · $102.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
Accriva DiagnosticsConstitution MedicalDelfi DiagnosticsHelixJHP PharmaceuticalsOsmindOutset MedicalParadigmSilk Road MedicalSingular BioSOC Telemed
Sources: SEC Form D filings · the firm's website · curated public sources.
Colleagues at DFJ
Frequently asked questions
- Who is Justin Kao?
- Justin Kao is a partner at DFJ Growth who invests in companies transforming human health. He co-founded Helix in 2015, serving as founding CEO and later chief business officer, where he led partnerships with health systems, payers, and life sciences companies and worked on the company's COVID-19 diagnostic testing efforts. Before DFJ Growth, he was a partner at Khosla Ventures and an investor at Warburg Pincus, and earlier worked at Boston Consulting Group and Onyx Pharmaceuticals. He holds a BS in chemical engineering and MS in bioengineering from Stanford, plus a JD from Stanford Law School and an MBA from Stanford Graduate School of Business.
- Where does Justin Kao work?
- Justin Kao is Partner at DFJ.
- What does Justin Kao invest in?
- Justin Kao invests in AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech.
- What check size does Justin Kao write?
- Justin Kao typically writes checks of $100K – $5M.
- What boards does Justin Kao sit on?
- Justin Kao holds tracked board seats at Delfi Diagnostics, Earli, Inflammatix, Inc..
- What companies has Justin Kao invested in?
- Investments tracked here include Accriva Diagnostics, Constitution Medical, Delfi Diagnostics, Earli, Helix, JHP Pharmaceuticals, Osmind, Outset Medical, Paradigm, Silk Road Medical, Singular Bio, SOC Telemed.
Founder mafias
Stanford University mafia2,290
Also came through, then founded or led a company.
Stanford University Graduate School of Business mafia976
Also came through, then founded or led a company.
Stanford Law School mafia33
Also came through, then founded or led a company.
Khosla Ventures mafia29
Also came through, then founded or led a company.
Warburg Pincus mafia26
Also came through, then founded or led a company.
About this profile. Compiled from public sources — DFJ's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights
































